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Abstract
Background: It remains a matter of debate whether colorectal cancer resection in an emergency setting negatively
impacts on survival. Our objective was therefore to assess the impact of urgent versus elective operation on overall
and disease-free survival in patients undergoing resection for colorectal cancer by using propensity score adjusted
analysis.
Methods: In a single-center study patients operated for colorectal cancer between 1989 and 2013 were identified
from a prospectively maintained database. Median follow-up was 44 months. Patients with neoadjuvant treatment
were excluded. The impact of urgent operation on overall and disease-free survival was assessed using both Cox
regression and propensity score analyses.
Results: Of 747 patients with colorectal cancer, 84 (11 %) had urgent and 663 elective cancer resection. The propensity
score revealed strongly biased patient characteristics (0.22 ± 0.16 vs. 0.10 ± 0.09; P < 0.001). In unadjusted analysis urgent
operation was associated with a 35 % increased risk of overall mortality (hazard ratio(HR) of death = 1.35, 95 %
confidence interval(CI):1.02–1.78, P = 0.045). In risk-adjusted Cox regression analysis urgent operation was not
associated with poor overall (HR = 1.08, 95 %CI:0.79–1.48; P = 0.629) or disease-free survival (HR = 1.02, 95 %CI:0.76–1.38;
P = 0.877). Similarly in propensity score analysis urgent operation did not influence overall (HR = 0.98, 95 % CI:0.74–1.29),
P = 0.872) and disease-free survival (HR = 0.89, 95 %CI:0.68 to 1.16, P = 0.387).
Conclusions: This study provides evidence that worse oncologic outcomes after urgent operation for colorectal cancer
are caused by clinical circumstances and not due to the urgent operation itself. Urgent operation is not a risk factor for
colorectal cancer resection.
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Background
Colorectal cancer remains one of the most prevalent
malignancies worldwide and a leading cause of cancer
related death. Surgical resection including systematic
lymphadenenctomy is the treatment of choice. Unfortu-
nately, only half of these curatively operated patients will
survive beyond five years. Up to 30 % of colorectal
cancer patients are first diagnosed during emergency
department presentation due to symptomatic disease
[1–3]. Previous studies demonstrated that mortality
rates are as much as four times higher for the immedi-
ate postoperative period in patients undergoing urgent
operation. Results concerning long time survival are
more conflicting [1–10]. However, many studies report
on rather small sample sizes, state only immediate post-
operative mortality rates or do not compare their re-
sults with a comparative group of electively operated
patients [4, 9, 11–14]. Retrospective study design as
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well as a small percentage of patients presenting as an
emergency make potential bias very likely. Randomisa-
tion could eliminate such bias but is not applicable for
these symptomatic patients. Propensity score matching
accounts for such bias in nonrandomized studies by
eliminating different distribution of observed variables
between two groups.
The objective of this study was to assess the impact
of urgent surgery on oncologic outcomes in a large
homogenic cohort of colorectal cancer patients. Both
Cox proportional hazard regression analyses as well as
propensity-scoring methods were used.
Methods
Data for the present retrospective study were extracted
from the prospectively maintained cancer registry data-
base at our institution, a tertiary care center in
Switzerland. Overall, 830 patients undergoing colorectal
cancer resection between 1989 and 2013 were identified.
Eighty patients with neoadjuvant therapy were excluded
as were three patients who were lost to follow-up. 747
patients remained for further analyses. Two groups were
compared, 84 patients with urgent operation and 663
patients who did undergo elective cancer resection. The
study was approved by the local ethical committee
(Ethikkommission Nordwest- und Zentralschweiz).
Follow-up data were collected from the treating general
practitioner of the respective patients. Approval of data
collection was obtained prior to surgery in years 1989–
2005. For patients operated between 2006 and 2013 con-
sent was obtained via letters of enquiry that were sent to
these patients.
Data collection and definitions
Data on patients’ demographics, mode of presentation,
operative details, postoperative mortality and histological
results were collected from the patients case notes. All op-
erations were performed or supervised by experienced
colorectal surgeons. Definition of urgent surgery was used
according to the NCEPOD classification of intervention
(e.g., immediate (within minutes), urgent (<hours), expe-
dited (<days) and elective (planned)) [15]. For the purpose
of this study, patients undergoing immediate or urgent
operations were grouped as urgent surgery. However, no
patients underwent immediate surgery within minutes
after emergency department presentation.
According to the postoperative staging adjuvant chemo-
therapy was administered routinely in patients with node
positive disease. Follow-up and recurrence data could be
almost entirely collected from our clinical records, or the
bureau of vital statistics and the treating physician,
respectively.
Statistical analyses
Statistical analyses were performed using the R statistical
software (www.r-project.org). A two-sided p-value < 0.05
was considered statistically significant. Continuous data
are expressed as means ± standard deviation. For com-
paring proportions, Chi-Square statistics and for com-
paring continuous variable, t-tests and Mann–Whitney
U-tests were used as appropriate. Missing data were im-
puted using the random survival forest method [16].
First, the bias concerning elective versus urgent oper-
ation was assessed regarding age, gender, tumor localisa-
tion, tumor stage, and adjuvant therapy. The same set of
covariates, including elective versus urgent operation
were then assessed as putative prognostic factors for
overall and disease-free survival in unadjusted and risk-
adjusted Cox regressions, including a backward variable
selection procedure from the full Cox regression model
based on the Akaike’s information criterion. Moreover, a
propensity score analysis as a superior and more refined
statistical method of adjusting for potential baseline con-
founding variables was performed [17–20]. We used the
“Matching” R package to perform a bipartite weighting
propensity score analysis [21, 22]. The baseline risk pro-
files of the matched patients were compared to assure
that no major differences in baseline patients character-
istics persisted. The prognostic value of elective versus
urgent operation for overall and disease-free survival
was finally assessed in a stratified Cox regression ana-
lysis applying the subclasses and the weights obtained by
the propensity score analysis.
Results
Patient characteristics and bias in urgent versus elective
operation
747 patients with a median follow-up time of 44 months
(range 0–247 months, mean 63.5 months) were eligible
for the present analysis. 84 patients underwent urgent
operation and 663 patients had elective cancer resection
as defined above. The 30 day postoperative mortality
rate was 5.2 % (35 of 663 patients) following curative re-
section and 8.3 % (7 of 84 patients) after urgent colorec-
tal cancer resection. In more than 90 % of patients
complete resection of the tumor could be achieved and
about half of the patients presented with node positive
disease (49.4 %, n = 369). Table 1 summarizes the char-
acteristics of patients with urgent and elective cancer re-
section. In univariate analysis tumor localisation,
perforation, resection status and number of extracted
lymph nodes significantly differed between patients with
urgent and elective operation (Table 1). After multivari-
able adjustment, number of extracted lymph nodes was
associated with urgent surgery and perforation was an
independent statistically significant predictor for urgent
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Table 1 Patient characteristics and bias for urgent versus elective operation













Age years 71.4 ± 12.1 72.0 ± 11.2 71.3 ± 12.2 0.884a 1.01 (0.99–1.03) 0.490 72.1 ± 11.3 72.5 ± 11.7 0.760a
Sex m 421 (56.4 %) 43 (51.2 %) 378(57.0 %) 0.311b Reference 0.517 42 (50.6 %) 333.5 (53.7 %) 0.594b
w 326 (43.6 %) 41 (48.8 %) 285 (43.0 %) 1.19
(0.71–1.99)
41 (49.4 %) 287.5 (46.3 %)
Tumor
localisation
Cecum 132 (17.7 %) 12 (14.3 %) 120 (18.1 %) 0.019b Reference 0.092 12 (14.5 %) 95.4 (15.4 %) 0.927b
Ascending colon 130 (17.4 %) 12 (14.3 %) 118 (17.8 %) 1.25 (0.50–3.19) 12 (14.5 %) 82.4 (13.3 %)
Transverse colon 40 (5.4 %) 7 (8.3 %) 33 (5.0 %) 2.50 (0.80–7.43) 7 (8.4 %) 55.7 (9.0 %)
Descending colon 81 (10.8 %) 12 (14.3 %) 69 (10.4 %) 2.29 (0.88–6.01) 12 (14.5 %) 80.9 (13.0 %)
Sigmoid colon 201 (26.9 %) 32 (38.1 %) 169 (25.5 %) 1.95 (0.90–4.44) 31 (37.3 %) 258.1 (41.6 %)
Rectum 163 (21.8 %) 9 (10.7 %) 154 (23.2 %) 0.78 (0.28–2.12) 9 (10.8 %) 48.7 (7.8 %)
Perforation No 674 (90.2 %) 56 (66.7 %) 618 (93.2 %) <0.001b Reference <0.001 56 (67.5 %) 465.5 (75.0 %) 0.144b
Yes 73 (9.8 %) 28 (33.3 %) 45 (6.8 %) 7.17 (3.93–13.09) 27 (32.5 %) 155.5 (25.0 %)
Protective colostomy No 657 (88.0 %) 71 (84.5 %) 586 (88.4 %) 0.306b Reference 0.129 70 (84.3 %) 512.7 (82.6 %) 0.687b
Yes 90 (12.0 %) 13 (15.5 %) 77 (11.6 %) 1.82 (0.83–3.80) 13 (15.7 %) 108.3 (17.4 %)
Resection status R0 718 (96.1 %) 76 (90.5 %) 642 (96.8 %) 0.014c Reference 0.114 76 (91.6 %) 571.8 (92.1 %) 0.870b
R1/2 29 (3.9 %) 8 (9.5 %) 21 (3.2 %) 2.32 (0.81–6.09) 7 (8.4 %) 49.2 (7.9 %)
UICC Stage I 166 (22.2 %) 13 (15.5 %) 153 (23.1 %) 0.332b Reference 0.599 13 (15.7 %) 69.9 (11.3 %) 0.698b
II 212 (28.4 %) 23 (27.4 %) 189 (28.5 %) 1.41 (0.63–3.29) 23 (27.7 %) 172.4 (27.8 %)
III 220 (29.5 %) 27 (32.1 %) 193 (29.1 %) 1.30 (0.55–3.15) 26 (31.3 %) 209.8 (33.8 %)
IV 149 (19.9 %) 21 (25.0 %) 128 (19.3 %) 1.83 (0.72–4.71) 21 (25.3 %) 168.9 (27.2 %)
Tumor diameter mm 45.8 ± 21.6 45.7 ± 20.6 45.8 ± 21.7 0.831a 0.99 (0.98–1.00) 0.107 45.6 ± 20.7 43.7 ± 19.3 0.421a
Lymph node yield <12 166 (22.2 %) 10 (11.9 %) 156 (23.5 %) 0.016b Reference 0.040 10 (12.0 %) 46.1 (7.4 %) 0.143b
12+ 581 (77.8 %) 74 (88.1 %) 507 (76.5 %) 2.08 (1.03–4.58) 73 (88.0 %) 574.9 (92.6 %)
Tumor grading G1 23 (3.1 %) 3 (3.6 %) 20 (3.0 %) 0.180b Reference 0.196 3 (3.6 %) 29.2 (4.7 %) 0.823b
G2 540 (72.3 %) 53 (63.1 %) 487 (73.5 %) 0.45 (0.14–2.03) 52 (62.7 %) 355.9 (57.3 %)
G3 148 (19.8 %) 21 (25.0 %) 127 (19.2 %) 0.62 (0.17–2.99) 21 (25.3 %) 175.1 (28.2 %)
GX 36 (4.8 %) 7 (8.3 %) 29 (4.4 %) 1.21 (0.26–6.73) 7 (8.4 %) 60.7 (9.8 %)
Adjuvant Chemotherapy No 505 (67.6 %) 51 (60.7 %) 454 (68.5 %) 0.152b Reference 0.785 51 (61.4 %) 382.8 (61.6 %) 0.973b
Yes 242 (32.4 %) 33 (39.3 %) 209 (31.5 %) 1.09 (0.59–2.01) 32 (38.6 %) 238.2 (38.4 %)
n (%); mean ± standard deviation
Number of patients after elective operation with decimals because of weigthing in the propensity score matching analysis












Table 2 Prognostic factors for overall and disease-free survival after colorectal cancer resection
Prognostic factors Overall survival Disease free survival
Unadjusteda Full modelb Backwards variable selectionc Unadjusteda Full modelb Backwards variable selectionc
HR (95 % CI) p * HR (95 % CI) p* HR (95 % CI) p* HR (95 % CI) p* HR (95 % CI) p * HR (95 % CI) p*
Cancer resection Elective Reference 0.045 Reference 0.629 – – Reference 0.043 Reference 0.877 – –
Urgent 1.35 (1.02–1.78) 1.08 (0.79–1.48) – – 1.33 (1.02–1.74) 1.02 (0.76–1.38) – –
Age years 1.04 (1.03–1.05) <0.001 1.05 (1.04–1.06) <0.001 1.05 (1.04–1.06) <0.001 1.03 (1.03–1.04) <0.001 1.04 (1.03–1.05) <0.001 1.04 (1.03–1.05) <0.001
Sex m Reference 0.973 Reference 0.850 – – Reference 0.478 Reference 0.381 – –
w 1.00 (0.84–1.20) 0.98 (0.81–1.19) – – 0.94 (0.79–1.12) 0.92 (0.76–1.11) – –
Tumor localisation Cecum Reference 0.004 Reference 0.002 Reference 0.003 Reference 0.018 Reference 0.026 Reference 0.031
Asc. colon 0.72 (0.53–0.96) 0.60 (0.44–0.82) 0.62 (0.46–0.83) 0.76 (0.57–1.02) 0.67 (0.49–0.91) 0.68 (0.50–0.91)
Transv. colon 0.81 (0.53–1.23) 0.62 (0.40–0.97) 0.63 (0.41–0.97) 0.78 (0.51–1.18) 0.62 (0.40–0.95) 0.63 (0.41–0.96)
Desc. olon 0.87 (0.62–1.22) 0.90 (0.63–1.28) 0.90 (0.64–1.27) 0.94 (0.68–1.31) 0.99 (0.70–1.39) 1.03 (0.74–1.45)
Sigm. colon 0.73 (0.56–0.95) 0.66 (0.50–0.88) 0.68 (0.51–0.89) 0.80 (0.62–1.04) 0.79 (0.60–1.05) 0.83 (0.63–1.08)
Rectum 0.56 (0.42–0.74) 0.57 (0.42–0.79) 0.58 (0.43–0.78) 0.62 (0.47–0.81) 0.70 (0.51–0.95) 0.74 (0.56–0.99)
Perforation No Reference 0.525 Reference 0.492 – – Reference 0.684 Reference 0.704 – –
Yes 1.10 (0.82–1.49) 1.13 (0.80–1.58) – – 1.06 (0.79–1.42) 1.07 (0.77–1.48) – –
Protec. colostomy No Reference 0.929 Reference 0.530 – – Reference 0.987 Reference 0.783 – –
Yes 1.01 (0.77–1.33) 1.10 (0.81–1.50) – – 1.00 (0.77–1.31) 1.04 (0.77–1.41) – –
Resection status R0 Reference <0.001 Reference 0.001 Reference <0.001 Reference <0.001 Reference 0.004 Reference 0.003
R1/2 3.21 (2.16–4.75) 2.22 (1.45–3.38) 2.30 (1.52–3.49) 3.07 (2.08–4.55) 1.97 (1.29–3.02) 1.97 (1.30–3.00)
UICC Stage I Reference <0.001 Reference <0.001 Reference <0.001 Reference <0.001 Reference <0.001 Reference <0.001
II 1.28 (0.97–1.69) 1.21 (0.89–1.64) 1.25 (0.93–1.67) 1.41 (1.08–1.85) 1.39 (1.03–1.87) 1.37 (1.03–1.82)
III 1.67 (1.27–2.19) 1.67 (1.22–2.29) 1.74 (1.29–2.36) 1.80 (1.38–2.34) 1.79 (1.31–2.43) 1.75 (1.30–2.36)
IV 4.02 (3.02–5.35) 4.89 (3.45–6.94) 5.10 (3.64–7.14) 4.83 (3.65–6.40) 5.64 (3.99–7.97) 5.58 (4.00–7.79)
Tumor diameter mm 1.00 (1.00–1.01) 0.071 1.00 (1.00–1.01) 0.730 – – 1.00 (1.00–1.01) 0.043 1.00 (1.00–1.01) 0.829 – –
Lymph node yield <12 Reference 0.662 Reference 0.006 Reference 0.007 Reference 0.662 Reference 0.173 – –
12+ 0.95 (0.77–1.18) 0.72 (0.57–0.91) 0.73 (0.58–0.91) 1.05 (0.85–1.29) 0.85 (0.68–1.07) – –
Tumor grading G1 Reference 0.012 Reference 0.367 – – Reference 0.001 Reference 0.009 Reference 0.007
G2 1.09 (0.65–1.82) 1.23 (0.72–2.09) – – 1.07 (0.65–1.77) 1.21 (0.72–2.03) 1.20 (0.72–2.00)
G3 1.58 (0.92–2.71) 1.41 (0.80–2.47) – – 1.66 (0.98–2.81) 1.45 (0.84–2.50) 1.42 (0.83–2.45)
GX 1.33 (0.69–2.57) 1.59 (0.81–3.14) – – 1.57 (0.84–2.95) 2.44 (1.27–4.68) 2.49 (1.31–4.73)
Adjuvant chemo. No Reference 0.679 Reference 0.042 Reference 0.027 Reference 0.501 Reference 0.142 Reference 0.142
Yes 0.96 (0.79–1.17) 0.77 (0.60–0.99) 0.76 (0.60–0.97) 1.07 (0.88–1.29) 0.84 (0.66–1.06) 0.84 (0.66–1.06)
HR Hazard ratios with 95 % confidence intervals (Wald type) and p-values of the likelihood ratio test
Prognostic factors for overall survival in:
*p values for likelihood ratio tes
aone Cox proportional hazards regression analyses for each factor
bCox proportional hazards regression analyses for all factors












operation (Table 1). Other differences in the patient
characteristics failed to reach the significance level.
Urgent operation as a prognostic factor for overall
survival
An unadjusted Cox proportional hazards regression ana-
lysis revealed urgent operation as a statistically signifi-
cant prognostic factor with an approximately 35 %
increased risk of overall mortality (HR of death = 1.35,
95 % CI: 1.02 to 1.78, P = 0.045) and an approximately
33 % increased risk of disease recurrence (HR of event =
1.33, 95 % CI: 1.02 to 1.74, P = 0.043) (Table 2). The
five-year overall survival for patients with urgent oper-
ation was 35.9 % (95 % CI: 26.1 to 49.4 %) compared to
50.8 % (95 % CI: 47.0 to 54.9 %) in patients with elective
operation (Fig. 1, left panel). The five-year disease-free
survival for patients with urgent operation was 30.6 %
(95 % CI: 21.6 to 43.3 %) compared to 45.0 % (95 % CI:
41.2 to 49.1 %) in patients undergoing elective operation
(Fig. 1, right panel). When adjusting for potential con-
founding factors in risk-adjusted Cox regression ana-
lyses, urgent operation did not influence overall survival
(HR of death = 1.08, 95 % CI: 0.79 to 1.48; P = 0.629) or
disease-free survival (HR of event = 1.02, 95 % CI: 0.76
to 1.38; P = 0.877). Elective versus urgent operation was
excluded from the full Cox regression models based on
the change in the Akaike’s information criterion as these
two variables did not show relevant predictive value for
OS and DFS(Table 2).
Propensity score analysis
The propensity score for patients who underwent urgent
operation was 0.22 ± 0.16 compared to 0.10 ± 0.09 in pa-
tients who underwent elective operation (P < 0.001), thus
indicating a strong bias regarding the patient characteris-
tics in the two groups. When performing the propensity
score matching procedure, 42 patients with elective oper-
ation and one patient with urgent operation had to be ex-
cluded because their characteristics could not be matched
with patients from the other group. Hence, the propensity
score-matched analysis was based on 704 patients. After
the matching procedure, the propensity score was virtually
the same in the two patient groups (0.21 ± 0.15 vs. 0.21 ±
0.15, P = 0.969). Fig. 2 displays the change in the distribu-
tion of the propensity score due to the matching proced-
ure. After adjusting the data according to the propensity
score analysis, urgent versus elective operation did not in-
fluence overall survival (HR = 0.98, 95 % CI: 0.74 to 1.29),
P = 0.872) and disease-free survival (HR = 0.89, 95 % CI:
0.68 to 1.16, P = 0.387) (Fig. 3).
Discussion
The present study is the first study using both Cox re-
gression analyses as well as propensity scoring methods
Fig. 1 Kaplan–Meier curve for overall and disease-free survival in unadjusted analysis. The number of colorectal cancer patients at risk are given
below each plot. Survival curves are provided with 95 % confidence intervals
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to assess the impact of urgent versus elective operation
on overall and disease-free survival in patients undergo-
ing resection for colorectal cancer. This study provides
evidence that patient characteristics are strongly biased
regarding urgent operation. Optimal adjustment for this
bias demonstrates no significant differences in overall
and disease-free survival neither after multivariable Cox
regression nor after propensity score-adjusted analyses.
In our study, 11 % of patients underwent urgent oper-
ation for colorectal cancer. This is comparable to other
published investigations [3, 8, 23], although some studies
report emergency presentation rates of up to 30 % [1, 2,
6, 10]. However, these studies did not clearly state
whether patients were operated within hours or have
been operated days after hospital admission. One of the
strengths of our study is the clear definition of urgent
surgery. This may account for the rather low percentage
of patients in this group.
Urgent operation was not associated with poor sur-
vival in our study. Although unadjusted risk analysis did
show reduced survival following urgent operation, this
difference was no longer of statistical relevance after
risk-adjustment. The increased risk observed in un-
adjusted analysis is clearly due to differences in baseline
characteristics and not due to the urgent operation itself.
Our results are supported by findings from recent stud-
ies which showed no statistical differences in long term
survival [5, 7, 9, 10]. These reports differ from some lar-
ger studies that reported poorer survival for colorectal
cancer patients presenting as an emergency [1–3, 6]. But
it is not clear from these studies to what extent adjuvant
therapy was administered and if so, differences were ob-
served between the investigated groups. Furthermore the
information if patients with neoadjuvant therapy were
included in the respective studies is not provided. In our
study, all patients receiving neoadjuvant treatment were
excluded and administration of adjuvant chemotherapy
was not different between the two groups. Adjuvant
chemotherapy was confirmed as an independent favor-
able prognostic factor for overall survival as well as the
number of harvested lymph nodes. Age, tumor location,
resection status, tumor stage, and affected lymph nodes
as well as tumor grade were confirmed to be independ-
ent prognostic factors for overall and disease free sur-
vival (Table 2). Besides these well known prognostic
factors, patients receiving urgent surgery significantly
more often presented with tumor perforation (Table 1).
This is explained by the fact that peritonitis on the basis
of perforated colorectal cancer is a common cause of
emergency department presentation [24]. However,
Fig. 2 Distribution of propensity scores before and after propensity score analysis. The left upper and lower panels show the distribution of the
propensity scores for patients with urgent and elective operation before the matching procedure. The right upper and lower panels demonstrate
the distribution of the propensity scores after bipartite propensity score matching
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tumor perforation failed to be a prognostic factor for
survival in our analysis. This is most likely based on the
fact that not only free intraperitoneal rupture of the
tumor was included in this group but also tumors show-
ing localized perforation or those with penetration of the
serosal surface in histological analysis.
Surprisingly, lymph node yield was higher in patients
undergoing urgent operation in the present study
(Table 1). Unfortunately, most of the published studies
do not state the amount of resected lymph nodes [1, 2,
4, 8–12]. This is somewhat surprising, giving the fact
that the number of harvested lymph nodes is crucial for
staging of colorectal cancer patients because lymph node
involvement represents the strongest prognostic factor
and serves as the most important selection criterion for
adjuvant chemotherapy [25]. Additionally, the number
of surgically removed and pathologically assessed lymph
nodes influences the staging accuracy and impacts over-
all survival [26, 27]. As a consensus standard, a mini-
mum of 12 examined lymph nodes per patient is
therefore recommended for accurate staging. In the
present investigation 88.1 % of urgent surgery and
76.5 % of elective surgery patients had ≥ 12 lymph nodes
resected (p = 0.016). This demonstrates that proper on-
cologic resection is achievable in urgent operations. Fur-
thermore, the comparable quality of oncologic resection
in both groups may be an explanation for the unobserved
differences in overall and disease-free survival. It is well
known from the literature that both, surgeon as well as
hospital specific specialisation and caseload are important
predictors for outcome after colorectal cancer resection
what seems to apply also for these results [28, 29].
Our study has several limitations. First, this is a retro-
spective cohort study and not a randomized controlled
trial. However, it is not possible to perform a random-
ized trial for this research question. A cohort study
adopting Cox regression analyses as well as propensity-
scoring methods probably represents the most appropri-
ate and highest-evidence level study design. Second,
while we did comprehensive risk-adjustment for ob-
served confounders, potential bias due to unknown or
unobserved confounders, such as American Society of
Anaesthesiologist (ASA) grade, comorbidities and adher-
ence to cancer related follow-up care, cannot be com-
pletely excluded. And last, all operations in this study
were performed or supervised by experienced surgeons
of a tertiary care center, what may also have influenced
survival rates.
Conclusion
In summary, urgent colorectal cancer resection does not
influence overall and disease-free survival after risk-
adjusting in multivariable Cox proportional as well as
propensity score analyses. The observed association
Fig. 3 Kaplan–Meier curve for overall and disease-free survival in propensity score adjusted analysis. The number of colorectal cancer patients at
risk are given below each plot. Survival curves are provided with 95 % confidence intervals
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between urgent operation and oncologic outcome is
caused by differences in patient and tumor characteristics.
Urgent operation itself is not a risk factor and colorectal
cancer resection should therefore not be postponed for
oncologic outcome reasons.
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